OTHER RIGHTS The Series Sample Clauses

OTHER RIGHTS The Series. D Preferred The Series D-1 Preferred has substantially the has substantially the same registration same registration rights, information rights, information rights, rights on rights, rights on transfers of securities transfers of securities etc. as the other series etc. as the other series of Pari Passu Preferred. of Pari Passu Preferred. *** EXHIBIT 2.1 TABLE A SERIES HORMOS SECURITIES CONVERTIBLE QUATRX STOCK SERIES NAME OF HORMOS SHAREHOLDER A SHARES SERIES B SHARES NOTES* COMMON STOCK SERIES D PREF D1 PREF -------------------------------------- --------- ----------------- ----------- ------------ ------------- --------- Aboa Venture II 16,393 5,875 302,693 31,517 125,314 Aaltonen Annukka 50 487 51 201 Ali-Rantala Mika 1,000 10,374 1,081 4,294 Anttila Markku 100 973 101 403 Apteekkien Elakekassa 5,500 653 69,622 7,250 28,823 Besodos Oy 3,000 36,051 3,754 14,925 Bio Fund Ventures I Ky 198,158 565,273 58,857 234,021 Bio Fund Ventures II Jatkosijoitusrahasto Ky 61,179 249,611 25,994 103,338 Bio Fund Ventures II Ky 29,921 550,382 57,307 227,856 Biomedical Venture III Ltd. (P/S) 146,872 2,744,038 285,718 1,136,024 Blom Taru 50 551 57 228 Backlund Anne 50 551 57 228 Eloranta Maire 160 1,686 176 698 Elakevakuutusosakeyhtio Veritas 5,511 1,453 784 96,601 10,058 39,992 Gronroos Paula 50 551 57 228 H&B Capital LP 86,395 1,614,134 168,069 668,247 Haapaniemi Marja-Leena 100 1,038 108 429 Halonen Kaija 10,100 60,866 93 373 Halonen Katriina 280 3,365 350 1,393 Halonen Minttu 100 973 101 403 Hannula Seija 400 3,893 405 1,611 Heinonen Sarita 50 551 57 228 Hellevuo Tia 50 551 57 228 Henkivakuutusosakeyhtio Veritas 2,755 726 392 48,286 5,028 19,990 Hirvela Leena 50 551 57 228 Huhtinen Kaisa 500 4,866 507 2,014 Harkonen Pirkko 28,000 167,514 132 527 Innoventure Oy 27,323 328,339 34,187 135,931 Johansson Nina 50 551 57 228 Jokela Riitta 50 487 51 201 Jarvenpaa Anna-Maija 100 973 101 403 Kalapudas Arja 150 1,524 158 631 Kangas Lauri 78,500 471,901 607 2,414 Karinkanta Minna 50 487 51 201 Karvonen Matti 83 914 95 379 Kaukoranta Pirkko 500 5,508 574 2,280 Keskinainen Elakevakuutusyhtio Ilmarinen 11,000 3,400 193,356 20,132 80,049 Keskinainen Elakevakuutusyhtio Tapiola 16,534 2,906 2,096 262,292 27,311 108,588 Keskinainen Henkivakuutusyhtio Suomi 22,000 4,000 336,338 35,020 139,244 Keskinainen Henkivakuutusyhtio Tapiola 8,267 1,743 1,079 134,589 14,014 55,719 Keskinainen Vakuutusyhtio Tapiola 11,023 2,906 1,502 190,575 19,843 78,897 Kiiskinen Mirja 50 551 57 228 Knuutila Vesa ...
Sample 1
AutoNDA by SimpleDocs

Related to OTHER RIGHTS The Series

  • Authorization of the Securities The Securities have been duly authorized and, at the Closing Time, will have been duly executed by the Company and, when authenticated, issued and delivered in the manner provided for in the Indenture and delivered against payment of the purchase price therefor as provided in this Agreement, will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, except as the enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all laws relating to fraudulent transfers), reorganization, moratorium or similar laws affecting enforcement of creditors’ rights generally and except as enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in a proceeding in equity or at law), and will be in the form contemplated by, and entitled to the benefits of, the Indenture.

  • Payment for the Securities Payment for the Securities shall be made at the Closing Date by wire transfer of immediately available funds to the order of the Company. It is understood that the Representatives have been authorized, for their own accounts and for the accounts of the several Underwriters, to accept delivery of and receipt for, and make payment of the purchase price for, the Securities that the Underwriters have agreed to purchase. The Representatives may (but shall not be obligated to) make payment for any Securities to be purchased by any Underwriter whose funds shall not have been received by the Representatives by the Closing Date for the account of such Underwriter, but any such payment shall not relieve such Underwriter from any of its obligations under this Agreement.

  • Authorization of the Shares The Shares have been duly authorized for issuance and sale pursuant to this Agreement and, when issued and delivered by the Company against payment therefor pursuant to this Agreement, will be validly issued, fully paid and nonassessable, and the issuance and sale of the Shares is not subject to any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase the Shares.

  • Adjustments Affecting the Securities The Company will not take any action, or permit any change to occur, with respect to the Securities that would materially and adversely affect the ability of the Holders to Consummate any Exchange Offer.

  • Authorization of the Sponsor Warrants The Company has duly authorized the issuance and sale of the Sponsor Warrants to the Purchaser.

  • Terms of the Sponsor Warrants (i) The Sponsor Warrants shall have their terms set forth in a Warrant Agreement to be entered into by the Company and a warrant agent, in connection with the Public Offering (a “Warrant Agreement”). (ii) At or prior to the time of the Initial Closing Date, the Company and the Purchaser shall enter into a registration rights agreement (the “Registration Rights Agreement”) pursuant to which the Company will grant certain registration rights to the Purchaser relating to the Sponsor Warrants and the Shares underlying the Sponsor Warrants.

  • Other Provisions Relating to Rights of Holders of Warrants 7.1 No Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter.

  • Payment for the Shares Payment for the Shares shall be made at the First Closing Date (and, if applicable, at the Second Closing Date) by wire transfer in immediately available-funds to the order of the Company. It is understood that the Representatives have been authorized, for their own account and the accounts of the several Underwriters, to accept delivery of and receipt for, and make payment of the purchase price for, the Firm Shares and any Option Shares the Underwriters have agreed to purchase. BancBoston Xxxxxxxxx Xxxxxxxx Inc., individually and not as a Representative of the Underwriters, may (but shall not be obligated to) make payment for any Shares to be purchased by any Underwriter whose funds shall not have been received by the Representatives by the First Closing Date or the Second Closing Date, as the case may be, for the account of such Underwriter, but any such payment shall not relieve such Underwriter from any of its obligations under this Agreement.

  • of the Series Supplement The REMIC Administrator and the Trustee shall not permit the creation of any "interests" (within the meaning of Section 860G of the Code) in any REMIC elected in respect of the Trust Fund other than the "regular interests" and "residual interests" so designated.

  • Terms of the Securities The Securities have the “Terms” as set out in these Issue Terms, which will complete and modify (i) the Bearer Securities Base Conditions Module, July 2016 Edition and (ii) the General Definitions Module, July 2016 Edition (the “General Definitions Module”), both of which are incorporated by reference into these Issue Terms (together, the “Conditions”) and are set out in full in the Information Memorandum.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!